Soligenix
SNGX
#11002
Rank
A$10.57 M
Marketcap
A$0.49
Share price
0.51%
Change (1 day)
-76.80%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -A$17.47 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$17.18 Million a decrease over its 2024 earnings that were of -A$13.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.47 Million1.68%
2025 -A$17.18 Million26.72%
2024 -A$13.56 Million22.96%
2023 -A$11.03 Million-45.74%
2022 -A$20.31 Million11.88%
2021 -A$18.16 Million-32.37%
2020 -A$26.85 Million83.18%
2019 -A$14.66 Million11.57%
2018 -A$13.14 Million19.29%
2017 -A$11.01 Million33%
2016 -A$8.28 Million-19.7%
2015 -A$10.31 Million5.16%
2014 -A$9.81 Million
2010 -A$11.07 Million26.12%
2009 -A$8.78 Million75.1%
2008 -A$5.01 Million-45.38%
2007 -A$9.18 Million-22.84%
2006 -A$11.89 Million66.15%
2005 -A$7.16 Million-16.65%
2004 -A$8.59 Million13.28%
2003 -A$7.58 Million-11.88%
2002 -A$8.6 Million-59.44%
2001 -A$21.21 Million378.18%
2000 -A$4.44 Million-38.53%
1999 -A$7.22 Million-18.43%
1998 -A$8.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.13 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.01 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.38 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$26.33 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$60.55 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.32 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$4 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA